This Expert Consensus Decision Pathway provides a focused update on the evaluation and management of mitral regurgitation, emphasizing a structured approach and timely intervention by a heart team.
This focused update provides a structured approach to the evaluation and management of mitral regurgitation, incorporating new trial data on secondary MR.
Mitral regurgitation (MR) is a complex valve lesion that can pose significant management challenges. This Expert Consensus Decision Pathway emphasizes that recognition of MR should prompt an assessment of its etiology, mechanism, and severity, as well as consideration of the indications for treatment. The document is a focused update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation, with some sections updated and others added in light of the publication of new trial data related to secondary MR, among other developments. A structured approach to evaluation based on clinical findings, accurate echocardiographic imaging, and, when necessary, adjunctive testing, can help clarify decision making. Treatment goals include timely intervention by an experienced multidisciplinary heart team to prevent left ventricular dysfunction, heart failure, reduced quality of life, and premature death.
“publication of practice-changing science”
Bonow et al. (Fri,) conducted a review in Mitral regurgitation. Management of Mitral Regurgitation was evaluated. This Expert Consensus Decision Pathway provides a focused update on the evaluation and management of mitral regurgitation, emphasizing a structured approach and timely intervention by a heart team.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: